Home > Healthcare > Pharmaceuticals > Finished Drug Form > Urothelial Cancer Drugs Market

Urothelial Cancer Drugs Market Trends

  • Report ID: GMI9754
  • Published Date: Jun 2024
  • Report Format: PDF

Urothelial Cancer Drugs Market Trends

  • Increasing prevalence of urothelial cancer significantly drives the growth of the market. For instance, as per an article published in January 2024, it has been reported that urothelial carcinoma is the 10th most common cancer globally with an almost 4 times higher prevalence in men. It is more prevalent in the elderly population with 80% of the cases getting diagnosed in people above 65 years of age.
  • Thus, the high prevalence of urothelial cancer necessitates an increasing demand for novel drug therapeutics, thereby driving market growth.
  • Moreover, the growing awareness and increase in cancer diagnostics rates for urothelial cancer contribute to an increased patient base seeking medical intervention, further boosting the market for these drugs.
  • Consequently, the rising prevalence of urothelial cancer not only increases the immediate demand for existing treatments but also stimulates ongoing innovation and market expansion in the long term.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global urothelial cancer drugs market was valued at USD 3.2 billion in 2023 and is anticipated to grow at 12.1% CAGR during 2024-2032, driven by rising prevalence of urothelial cancer, particularly bladder cancer.

The urothelial carcinoma segment of the market recorded a revenue of USD 1.7 billion in 2023, owing to its high prevalence.

North America urothelial cancer drugs market secured 40.5% revenue share in 2023 and is expected to dominate through 2032, owing to high levels of awareness about cancer and robust screening programs.

Gilead Science, Inc, Johnson & Johnson (Janssen Biotech), Merck & Co. Inc, Merck KGaA, Novartis AG, Pfizer, Inc, and UroGen Pharma, Inc among others.

Urothelial Cancer Drugs Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 326
  • Countries covered: 22
  • Pages: 186
 Download Free Sample